Aktieanalys

BioArctic Q3 2024: Positive CHMP opinion a relief for the share - Redeye

{newsItem.title}

Redeye Publicerad: 18 Nov 11:43

Redeye return with a research update following BioArctic's Q3 report and recent events, including the positive CHMP opinion and new FY2024 forecast from Eisai.

Länk till analysen i sin helhet: https://www.redeye.se/research/1058215/bioarctic-q3-2024-positive-chmp-opinion-a-relief-for-the-share-2?utm_source=finwire&utm_medium=RSS

Nyheter om BioArctic

Läses av andra just nu

Om aktien BioArctic

Senaste nytt